Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00131534 · ClinicalTrials.gov registry record
The Trauma Recovery and Resiliency Research Project
A clinical trial, sponsored by Cambridge Health Alliance.
- Completed
- Registry status
- 969
- Enrollment target
NCT00131534: Completed study, sponsored by Cambridge Health Alliance.
NCT00131534 is a clinical trial that has completed, run by Cambridge Health Alliance. The registered enrollment target is 969 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00131534 has completed, sponsored by Cambridge Health Alliance.
- COMPLETED
- Registry status
- 969 participants
- Enrollment target
Study Summary
The overall purpose of this study is the assessment of treatment outcome among traumatized patients seeking individual and/or group therapy at the Victims of Violence Program. The study gathers information from patients using quantitative (self-report) and qualitative (interview-based) approaches, to determine changes in symptom patterns and domains of functioning relevant to psychological trauma.
Interventions
- BEHAVIORAL Individual therapy
- BEHAVIORAL Group therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 969 participants |
| Start Date | 1991-08 |
| Est. Completion | 2012-01 |
What the finished NCT00131534 record still lists
NCT00131534 is an observational study that tracks outcomes without assigning an intervention. The registered 969 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Individual therapy is the first listed.
NCT00131534 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00131534 about?
NCT00131534 is a clinical study titled "The Trauma Recovery and Resiliency Research Project". The overall purpose of this study is the assessment of treatment outcome among traumatized patients seeking individual and/or group therapy at the Victims of Violence Program. The study gathers information from patients using quantitative (self-report) and qualitative (interview-based) approaches, t...
What is the current status of trial NCT00131534?
This trial is currently completed. The enrollment target is 969 participants. The study started on 1991-08. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00131534?
The interventions under investigation include: Individual therapy (BEHAVIORAL), Group therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00131534?
This trial is sponsored by Cambridge Health Alliance, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05354141 · 970 participants · Phase 3
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
- NCT06948422 · 974 participants · Phase 3
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
- NCT05600777 · 975 participants · Phase 3
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
- NCT06541704 · 975 participants · Phase 3
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia